CTRI/2021/09/036321已完成未知
Comparative study of Rifaximin alone versus combination therapy with Norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis with hepatic encephalopathy
Pt BD Sharma PGIMS Rohtak0 个研究点目标入组 49 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 49
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients with cirrhosis and ascites with hepatic encephalopathy with either gastrointestinal bleed, shock (systolic blood pressure <90 mmHg), fever or other signs of systemic inflammation like pain abdomen, diarrhea as well as in patients with worsening liver or renal function and hepatic encephalopathy shall be screened for spontaneous bacterial peritonitis by diagnostic paracentesis
排除标准
- •1. Age <18 years or > 70 years
- •2. Pregnant females
- •3. Patients with chronic respiratory or kidney disease
- •4. Patients with diabetes mellitus or hypertension
- •5. Patients with hepatocellular carcinoma
- •6. Patients with abnormal ECG or chest radiograph
研究者
相似试验
已完成
3 期
The therapeutic effects of rifaximin in diarrhea-predominant irritable bowel syndromediarrhea-predominant irritable bowel syndrome.K58.0Irritable bowel syndrome with diarrheaIRCT20141201020178N12Iran University of Medical Sciences150
已完成
3 期
The effect of rifaximin in different doses on symptoms and quality of life improvement in Iranian patients with diarrhea-predominant irritable bowel syndromeIrritable bowel syndrome with diarrheaIRCT20141201020178N11Iran University of Medical Sciences200
尚未招募
Unknown
The effect of Rifaximin (an antibiotic drug commonly used in liver failure patients) and standard medical therapy vs standard medical therapy alone on myosteatosis (fat deposition in abdominal muscles), in patients with decompensated cirrhosis- a randomized controlled trialCTRI/2024/07/069984PGIMER, CHANDIGARH
招募中
2 期
Prospective study on suppression of cholangitis using rifaximin after SEMS placement for distal malignant biliary obstructioJPRN-jRCTs051210173Ikezawa Kenji30
进行中（未招募）
不适用
Effects of rifaximin administration in patients with severe acute alcoholic hepatitis. Comparative pilot study.EUCTR2012-000515-80-ESJuan Córdoba